Daily ear vagus‑nerve stimulation to reduce TMD jaw and facial pain
Official title: Evaluating Noninvasive Brain Stimulation for TMD Pain: A Feasibility Study
Run by University of Minnesota · NCT07517172 · Data updated 2026-11-12
This will test whether daily, at‑home gentle electrical stimulation of the ear's vagus nerve can reduce chronic jaw and facial pain in adults with temporomandibular disorder (TMD).
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | May 20, 2026 |
| Main results expected | September 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | May 29, 2026 |
| Trial ID | NCT07517172 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with a DC‑TMD diagnosis, at least 3 months of pain scoring ≥4/10, who can read English, have a smartphone or computer, and are willing to self‑administer daily tAN at home are ideal candidates.
✕Probably not a fit
People with certain neurological disorders (for example epilepsy, stroke, multiple sclerosis, or traumatic brain injury), implanted neuromodulation devices, unstable severe psychiatric conditions, or those unable/unwilling to self‑administer home stimulation or attend visits are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double‑blind, sham‑controlled feasibility trial will enroll about 40 adults with chronic TMD to try daily transcutaneous auricular neurostimulation (tAN) at home. Participants will be randomly assigned to active or sham stimulation and will self‑administer mild electrical pulses to the auricular branch of the vagus nerve while researchers monitor adherence and retention. The study will track changes in pain intensity, cognitive flexibility, and mood using validated questionnaires and wearable smartwatch data. Results are intended to inform whether a larger clinical trial is warranted and whether tAN could be a practical non‑pharmacologic option for people who have not responded to standard TMD treatments.
Why it matters
Potential benefit: If successful, this approach could offer a noninvasive, drug‑free way to lower chronic orofacial pain and improve related mood and cognitive symptoms for people with TMD.
How similar studies have gone: Early small studies of noninvasive auricular vagus stimulation have shown promising signals for pain and mood, but its use specifically for chronic TMD is still largely untested and requires larger trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 65 years. * Diagnosis of temporomandibular disorder (TMD) based on the Diagnostic Criteria for Temporomandibular Disorders (DC-TMD). * Pain intensity of at least 4/10 on the Numeric Rating Scale (NRS) over the past two weeks. * Chronic pain duration of at least three months, consistent with diagnosis of chronic TMD. * Willingness to self-administer transcutaneous auricular nerve stimulation (tAN) at home and comply with study procedures. * Fluency in English to ensure comprehension of study materials and assessments. * Access to a smartphone or computer with internet to complete electronic study surveys and check-ins with the research team. Exclusion Criteria: * Neurological conditions that may interfere with study outcomes, including epilepsy, stroke, multiple sclerosis, or traumatic brain injury. * Use of implanted neuromodulation devices, such as vagus nerve stimulators, deep brain stimulators, or cochlear implants. * Unstable or severe psychiatric disorders, including active psychosis or severe depression with suicidal ideation. * Pregnancy or intention to become pregnant during the study period. * Skin conditions or other contraindications that prevent safe electrode placement on the auricular region (e.g., metal in the cymba concha that is unable or not willing to remove). * History of trauma (e.g., skull fracture) or periauricular surgery (e.g., temporomandibular joint replacement, acoustic neuroma removal) which would affect the location and function of the target peripheral innervation. * Use of both surgical and non-surgical bone conduction hearing devices.
Where it's running
-
University of Minnesota
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Donald Nixdorf, MD — University of Minnesota
- Study coordinator: Carla Campbell
- Email: ohcrc@umn.edu
- Phone: 612-625-6976
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Botulinum toxin for jaw myofascial pain in adults
This study tests whether injecting botulinum toxin into jaw muscles helps reduce pain and improve mouth opening in adults with stubborn temporomandibular myofascial pain.
-
What predicts how bad TMD is, involving jaw, neck, and posture
We will test if jaw dysfunction, neck position sense, and head/neck posture relate to how severe temporomandibular disorders are in adults.
-
Nerivio in adults and adolescents with chronic TMD headache
This study tests a Nerivio device to help people 12 and older with chronic temporomandibular disorder and headaches see if the treatment reduces pain.
-
Heat therapy for jaw pain in chronic TMD
This study tests whether applying local heat to the jaw can reduce pain and jaw fatigue in adults with chronic temporomandibular disorder during a clenching task.
-
Using Botulinumtoxin A to treat pain in jaw disorders
This study is testing if Botulinumtoxin A injections can help reduce pain and improve life for people with jaw disorders caused by muscle issues.
-
Investigating the link between levonorgestrel intrauterine system and temporomandibular disorders
This study is trying to see if using a specific birth control device called the levonorgestrel intrauterine system is linked to jaw joint problems in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.